New clinical guidance for iOAT take-home doses! Nouveau guide clinique pour les doses à emporter iOAT

This guidance document provides recommendations to healthcare clinics and providers that are interested learning more about offering take-home doses of iOAT to their clients.

Evidence indicates that take-home doses can enhance client-centred care and accessibility without compromising safety. Please click here for a summary of the evidence that informs this work.

Please use the links below to download the full guidance, and consider sharing with your teams, colleagues and anyone else who you think would be interested! It is free and available to anyone who needs it.

(english version)

(version française)

Funding for this guidance document was provided by Health Canada’s Substance Use and Addictions Program.